Andrew Huberman· PhD
collectively the overall survival increase for patients with metastatic solid organ tumors is about 8% better than it was 50 years ago and virtu all of that has come from some form of immunotherapy
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
collectively the overall survival increase for patients with metastatic solid organ tumors is about 8% better than it was 50 years ago and virtu all of that has come from some form of immunotherapy
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I still believe that immunotherapy is probably the most important hope we have for treating cancer and well I think we're still only scratching the surface of it so collectively the overall survival increase for patients with metastatic solid organ tumors is about 8% better than it was 50 years ago and virtually all of that has come from some form of immunotherapy